The FDA and NIH dispute reports that clinical trial data is being under-reported.
Daily News Roundup
The FDA and NIH dispute reports that clinical trial data is being under-reported.
Principal investigators with medical training have a slightly higher NIH funding rate than those with just a PhD.
The newly appointed chief of one Institute gives up his appointment days before starting.
A scientist who claimed to have injected monkey embryonic stem cells into the eyes of rats to improve their vision accepts the penalty for research misconduct.
Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.
A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
Extra inches may mean a higher chance of getting ovarian cancer.
Researchers put the predictive power of whole genome sequencing to the test.
Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.